Page 2 - இன்டாஸ் பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இன்டாஸ் பார்மா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இன்டாஸ் பார்மா Today - Breaking & Trending Today

ChrysCapital announces investment in Corona Remedies

ChrysCapital announces investment in Corona Remedies
By
IANS
|
Published on
Mon, Apr 5 2021 20:57 IST
|
9 Views

CFMA sees poetic justice for MF investors through 6 FTMF shut funds case in SC.. Image Source: IANS News
New Delhi, April 5 : ChrysCapital, one of the leading private equity funds in India, has announced its investment in Corona Remedies Private Limited (Corona), one of the country s fastest growing pharmaceutical companies, by acquiring a 27 per cent stake through an entirely secondary deal.
Commenting on the investment, Kshitij Sheth, Director, ChrysCapital, said, ChrysCapital is very excited to partner with Corona in its growth journey. The domestic pharmaceutical market is a large, attractive and resilient market with a healthy outlook. Corona is among the fastest growing companies in the Indian pharmaceutical market with presence in exciting therapeutic areas including cardiology, diabetology and gynae ....

New Delhi , Ankur Mehta , Intas Pharma , Zydus Cadila , Nirav Mehta , Shardul Amarchand Mangaldas , Kshitij Sheth , Corona Remedies Private Limited , Founder Director , Capital Advisors , Vertices Partners , Mankind Pharma , Eris Lifesciences , Torrent Pharma , Ipca Labs , Curatio Healthcare , புதியது டெல்ஹி , அன்குர் மேத்தா , இன்டாஸ் பார்மா , ஜய்துச் காடிலா , நீரவ் மேத்தா , ஷார்துள் அமர்சந்த் மங்கல்தாஸ் , க்ஷித்ிஜ் உறை , கொரோனா வைத்தியம் ப்ரைவேட் வரையறுக்கப்பட்டவை , நிறுவனர் இயக்குனர் , செங்குத்துகள் கூட்டாளர்கள் ,

ChrysCap to buy 30% in Corona Remedies for Rs 670 crore

ChrysCap to buy 30% in Corona Remedies for Rs 670 crore
SECTIONS
Share
Synopsis
ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days.
Reuters
Homegrown private equity fund ChrysCapital will invest about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies.
ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days. ....

Andhra Pradesh , Brahmal Vasudevan , Chandra Pharmalab , Intas Pharma , Jb Chemicals Pharmaceuticals For Rs , Advent International , Spark Capital , Kuala Lumpur Based Creador , Corona Remedies , Active Pharmaceutical Ingredients , Mankind Pharma , Eris Lifesciences , Sequent Scientific , Minority Stake , Abbott India , ஆந்திரா பிரதேஷ் , இன்டாஸ் பார்மா , ஜ்ப் இரசாயனங்கள் மருந்துகள் க்கு ர்ச் , தீப்பொறி மூலதனம் , கொரோனா வைத்தியம் , செயலில் மருந்து பொருட்கள் , மனிதகுலம் பார்மா , எரிஸ் ஆயுள் அறிவியல் , தொடர்ச்சி அறிவியல் , சிறுபான்மை பங்கு , அப்போட் இந்தியா ,